Article Information
History
- July 10, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Christopher Maucourant1,*,
- Iva Filipovic1,*,
- Andrea Ponzetta1,*,
- Soo Aleman2,
- Martin Cornillet1,
- Laura Hertwig1,
- Benedikt Strunz1,
- Antonio Lentini3,
- Björn Reinius3,
- Demi Brownlie1,
- Angelica Cuapio Gomez1,
- Eivind Heggernes Ask4,
- Ryan M. Hull5,
- Alvaro Haroun-Izquierdo1,
- Marie Schaffer1,
- Jonas Klingström1,
- Elin Folkesson2,
- Marcus Buggert1,
- Johan K. Sandberg1,
- Lars I. Eriksson6,8,
- Olav Rooyackers7,8,
- Hans-Gustaf Ljunggren1,
- Karl-Johan Malmberg1,3,9,
- Jakob Michaëlsson1,
- Nicole Marquardt1,
- Quirin Hammer1,
- Kristoffer Strålin2,
- Niklas K. Björkström1,†,
- Karolinska COVID-19 Study Group
- 1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- 2Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
- 3Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
- 4Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
- 5SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden
- 6Department of Physiology and Pharmacology, Section for Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden
- 7Department Clinical Interventions and Technology CLINTEC, Division for Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden
- 8Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden
- 9The KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- ↵†Corresponding author. Email: niklas.bjorkstrom{at}ki.se
↵* Equal contribution.